Press Releases for ACAD

Press Releases
ACADIA Pharmaceuticals Reports Second Quarter 2009 Financial Results
ACADIA Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 5, 2009
ACADIA Pharmaceuticals to Present at the Eighth Annual Needham Life Sciences Conference on June 10, 2009
ACADIA Pharmaceuticals to Present at the Eighth Annual JMP Securities Research Conference on May 19, 2009
ACADIA Pharmaceuticals Reports First Quarter 2009 Financial Results
ACADIA Pharmaceuticals and Biovail Announce Completion of Enrollment in First Pivotal Phase III Trial with Pimavanserin in Patients with Parkinson’s Disease Psychosis
Biovail Reports First-Quarter 2009 Financial Results
ACADIA Pharmaceuticals to Announce First Quarter 2009 Financial Results on May 11, 2009
ACADIA Pharmaceuticals and Biovail Form Collaboration to Develop and Commercialize Pimavanserin in North America
ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2008
ACADIA Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference on March 11, 2009
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2008 Financial Results on March 9, 2009
ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009
ACADIA Pharmaceuticals Awarded Grant from The Michael J. Fox Foundation for the Development of Novel ER-beta Agonists for the Treatment of Parkinson’s Disease
ACADIA Pharmaceuticals to Present at The 20th Annual Piper Jaffray Health Care Conference on December 3, 2008
ACADIA Pharmaceuticals Reports Third Quarter 2008 Financial Results
ACADIA Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008
ACADIA Pharmaceuticals to Announce Third Quarter 2008 Financial Results on November 5, 2008
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences - Oct 21 2008 9:23AM
ACADIA Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference on October 6, 2008
ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing Facility
Analyst Reports for Electronic Arts Inc., Teva Pharmaceutical Industries Limited, ACADIA Pharmaceuticals Inc., And Sport Supply Group Inc.
ACADIA Pharmaceuticals to Present at The Thomas Weisel Partners Healthcare Conference on September 4, 2008
ACADIA Pharmaceuticals Secures Committed Equity Financing Facility
ACADIA Pharmaceuticals Announces Second Quarter 2008 Financial Results and Strategic Restructuring
ACADIA Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
ACADIA Pharmaceuticals Announces Results from ACP-104 Phase IIb Schizophrenia Trial
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences - Jun 4 2008 9:30AM
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences - May 27 2008 12:52AM
ACADIA Pharmaceuticals Reports First Quarter 2008 Financial Results - Jun 1 2008 6:30AM
ACADIA Pharmaceuticals Announces Election of Laura A. Brege to Board of Directors - Jun 1 2008 6:30AM
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences - Jun 1 2008 6:29AM
ACADIA Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 5, 2008
ACADIA Pharmaceuticals to Present Data from Its Phase II Trial with Pimavanserin for Parkinson's Disease Psychosis at the 60th American Academy of Neurology Annual Meeting
ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104, ACP-105 and Its Muscarinic Discovery Program at Experimental Biology 2008 Meeting